SCHEMBL16410827

SCHEMBL16410827

[N-]=[N+]=NCS(=O)(=O)c1ccc(CNNC2=Nc3ccccc3NC23CCOCC3)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16410735 0.78 — —
SCHEMBL16410616 0.77 ACAT2 (0.39) —
SCHEMBL16410796 0.76 ACAT2 (0.30) —
SCHEMBL16410795 0.76 — —
SCHEMBL16410708 0.75 — —
SCHEMBL17757026 0.75 PTGS2 (0.35) —
SCHEMBL16410601 0.74 — —
SCHEMBL16410742 0.73 CA12 (0.33) —
SCHEMBL16410622 0.71 KMT2A (0.37) —
SCHEMBL16410722 0.71 OGA (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015007730-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2015-01-22 — — WO disclosed
Send feedback